Cargando…
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
The coronavirus disease (COVID-19) pandemic, resulting from human-to-human transmission of a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has led to a global health crisis. Given that the 3 chymotrypsin-like protease (3CLpro) of SARS-CoV-2 plays an indispensable role in viral po...
Autores principales: | Chiou, Wei-Chung, Chen, Jui-Chieh, Chen, Yun-Ti, Yang, Jinn-Moon, Hwang, Lih-Hwa, Lyu, Yi-Shuan, Yang, Hsin-Yi, Huang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787066/ https://www.ncbi.nlm.nih.gov/pubmed/33454058 http://dx.doi.org/10.1016/j.bbrc.2020.12.106 |
Ejemplares similares
-
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
por: Tan, Haozhou, et al.
Publicado: (2022) -
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
por: Tan, Haozhou, et al.
Publicado: (2022) -
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
por: Chiou, Wei-Chung, et al.
Publicado: (2021) -
PGG.Han: the Han Chinese genome database and analysis platform
por: Gao, Yang, et al.
Publicado: (2020) -
Synthesis, characterization, and in vivo efficacy evaluation of PGG–docetaxel conjugate for potential cancer chemotherapy
por: Yang, Danbo, et al.
Publicado: (2012)